Editor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement

Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Editor Choice:  Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial

Hosted by: Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta Canada
Featuring: Janice S. Kwon  MD, MPH, FRCSC, University of British Columbia, Vancouver, Canada and  R. Wendel Naumann, MD Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 28203, USA

https://www.gynecologiconcology-online.net/article/S0090-8258(26)00001-6/

https://www.gynecologiconcology-online.net/article/S0090-8258(26)00789-4/

Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology
Featuring:
Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USA
Christina M. Annunziata, American Cancer Society, Atlanta, GA, USA

https://www.gynecologiconcology-online.net/article/S0090-8258(25)01083-2/

https://www.gynecologiconcology-online.net/article/S0090-8258(25)01139-4/

Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Editor’s Choice: Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches

Hosted by: Paola A Gehrig, MD University of Virginia Charlottesville, Virginia United States
Featuring:
Lee-may Chen, MD; Division of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States
Esther Vermaas; Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
J.W.M. Aarts, MD, PhD; Principal Investigator and Gynaecological oncologist Amsterdam University Medical Centers, location VUMC, the Netherland

https://www.gynecologiconcology-online.net/article/S0090-8258(25)01048-0/

https://www.gynecologiconcology-online.net/article/S0090-8258(25)01103-5/

Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Editor’s Choice: Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant

Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology

Featuring:
William Cliby, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA
Chiara Ainio, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA
Oliver Zivanovic, Clinic for Gynecology and Obstetrics, Heidelberg University Hospital, Heidelberg, Germany

Editor’s Choice: Integration of self-hypnosis in an enhanced recovery after surgery program in gynecologic oncology – A prospective randomized trial

Editorial: Relax - It’s evidence-based: The role of hypnosis in managing post-operative symptoms

Editor’s Choice: Integration of self-hypnosis in an enhanced recovery after surgery program in gynecologic oncology – A prospective randomized trial

Editorial: Relax - It’s evidence-based: The role of hypnosis in managing post-operative symptoms

Editor’s Choice: TROP2 expression and therapeutic targeting in uterine carcinosarcoma

Editorial: The search for new therapeutic options for uterine carcinosarcoma